Literature DB >> 10704655

A rapid method to visualize von willebrand factor multimers by using agarose gel electrophoresis, immunolocalization and luminographic detection.

D R Krizek1, M E Rick.   

Abstract

A highly sensitive and rapid clinical method for the visualization of the multimeric structure of von Willebrand Factor in plasma and platelets is described. The method utilizes submerged horizontal agarose gel electrophoresis, followed by transfer of the von Willebrand Factor onto a polyvinylidine fluoride membrane, and immunolocalization and luminographic visualization of the von Willebrand Factor multimeric pattern. This method distinguishes type 1 from types 2A and 2B von Willebrand disease, allowing timely evaluation and classification of von Willebrand Factor in patient plasma. It also allows visualization of the unusually high molecular weight multimers present in platelets. There are several major advantages to this method including rapid processing, simplicity of gel preparation, high sensitivity to low concentrations of von Willebrand Factor, and elimination of radioactivity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10704655     DOI: 10.1016/s0049-3848(99)00196-6

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  7 in total

1.  Correction of a murine model of von Willebrand disease by gene transfer.

Authors:  Robert G Pergolizzi; Guangchun Jin; Diane Chan; Lorraine Pierre; James Bussel; Barbara Ferris; Philip L Leopold; Ronald G Crystal
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

2.  Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice.

Authors:  David G Motto; Anil K Chauhan; Guojing Zhu; Jonathon Homeister; Colin B Lamb; Karl C Desch; Weirui Zhang; Han-Mou Tsai; Denisa D Wagner; David Ginsburg
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

3.  Sodium dodecyl sulfate agarose gel electropheresis and electroelution of high molecular weight human salivary mucin.

Authors:  Matthias Gabriel; Andrej Zentner
Journal:  Clin Oral Investig       Date:  2005-08-25       Impact factor: 3.573

4.  Bleeding complications after arthroscopy in a JAK2V617F-positive patient with essential thrombocythemia and acquired von Willebrand syndrome (AVWS).

Authors:  Joanna Rupa-Matysek; Krzysztof Lewandowski; Maria Lewandowska; Ewelina Wojtasińska; Marzena Liliana Wojtaszewska; Michał Walczak; Ksenia Bykowska; Mieczysław Komarnicki
Journal:  Int J Hematol       Date:  2014-11-29       Impact factor: 2.490

5.  Paradoxical Effect of Nonphysiological Shear Stress on Platelets and von Willebrand Factor.

Authors:  Zengsheng Chen; Nandan K Mondal; Jun Ding; Steven C Koenig; Mark S Slaughter; Zhongjun J Wu
Journal:  Artif Organs       Date:  2015-11-18       Impact factor: 3.094

Review 6.  The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology.

Authors:  Mike A Laffan; Will Lester; James S O'Donnell; Andrew Will; Robert Campbell Tait; Anne Goodeve; Carolyn M Millar; David M Keeling
Journal:  Br J Haematol       Date:  2014-08-12       Impact factor: 6.998

7.  The CentriMag centrifugal blood pump as a benchmark for in vitro testing of hemocompatibility in implantable ventricular assist devices.

Authors:  Chris H H Chan; Ina Laura Pieper; Rebecca Hambly; Gemma Radley; Alyssa Jones; Yasmin Friedmann; Karl M Hawkins; Stephen Westaby; Graham Foster; Catherine A Thornton
Journal:  Artif Organs       Date:  2014-07-28       Impact factor: 3.094

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.